The role of paraoxonases in the pathogenesis of inflammatory and infectious diseases and cancer

Levakov S.A., Sheshukova N.A., Obukhova E.A., Antipova N.V., Shakhparonov M.I.

1) Department of Obstetrics and Gynecology, Faculty of General Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia; 2) Academicians M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia; 3) Peoples’ Friendship University of Russia, Moscow, Russia
The paraoxonase (PON) gene family contains three members: PON1, PON2, and PON3. All the three members of the family possess antioxidant properties and lipo-lactonase activity, and play a role in the pathogenesis of many inflammatory diseases, including atherosclerosis, Alzheimer’s and Parkinson’s diseases, diabetes mellitus, and cancer. Recent studies have demonstrated that the intracellular paraoxonases PON2 and PON3 associated with mitochondria and mitochondria-associated endoplasmic reticulum membranes regulate mitochondrial superoxide production and prevent apoptosis. As oxidative stress is a result of mitochondrial dysfunction and is involved in the development of inflammatory diseases, including atherosclerosis and cancer, the studies of the enzymes PON2 and PON3 can initiate many epidemiological surveys conducted to search for a relationship between the paraoxonase genes and the development of many inflammatory diseases. Understanding these mechanisms will be able to introduce new treatments for oxidative stress-related diseases.

Keywords

antioxidants
atherosclerosis
cancer
endoplasmic reticulum stress
inflammation
paraoxonase 1
paraoxonase 2
paraoxonase 3
bacterial quorum sensing

References

  1. Duhig K., Chappell L.C., Shennan A.H. Oxidative stress in pregnancy and reproduction. Obstetric Medicine. 2016; 9(3): 113–6. doi:10.1177/1753495X16648495.
  2. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. In: Halliwell, B. and Gutteridge, J.M.C., eds., Free Radicals in Biology and Medicine, 3rd Edition, Oxford University Press, Oxford. 1999: 1-25.
  3. Cadenas E., Davies K.J.A. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med. 2000; 29: 222–30. doi: 10.1016/s0891-5849(00)00317-8
  4. Furlong C.E., Marsillach J., Jarvik G.P., Costa L.G. Paraoxonases-1, -2 and -3: What are their functions? Chemico-Biological Interactions. Chem Biol Interact. 2016; 259(Pt B): 51–62. doi: 10.1016/j.cbi.2016.05.036.
  5. Ефимцева Э.А., Челпанова Т.И. Параоксоназа: молекулярно-генетические аспекты и клиническое значение. Успехи современной биологии. 2012; 132(3): 282–96. [Efimtseva E.A., Chelpanova T.I. Paraoxonase: Molecular Genetic Aspects and Clinical Value. Uspekhi sovremennoy biologii. 2012; 132(3): 282–96. (in Russian)].
  6. She Z.G., Chen H.Z., Yan Y., Li H., Liu D.P. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal. 2012; 16: 597–632. doi: 10.1089/ars.2010.3774.
  7. Курдюков И.Д. Параоксоназа-1: генетические, биохимические и токсикологические аспекты. Профилактическая токсикология. 2011; 48–55. [Kurdukov I.D. Paraoxinase-1: genetic, biochemical and toxicological aspects. Profilakticheskaya toksikologiya. 2011; 48–55. (in Russian)].
  8. Garcia-Heredia A., Kensicki E., Mohney R.P., Rull A., Triguero I., Marsillach J., et al. Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach. J Proteome Res. 2013; 12: 1946–55. doi: 10.1021/pr400050u
  9. Bhattacharyya T., Nicholls S.J., Topol E.J., Zhang R., Yang X., Schmitt D., et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA. 2008; 299: 1265–76. doi: 10.1001/jama.299.11.1265.
  10. Stevens R.S., Suzuki S.M., Cole T.B., Park S.S., Richter R.J., Furlong  C.E. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc Natl Acad Sci USA. 2008; 105(35): 12780-4. doi: 10.1073/pnas.0805865105.
  11. Stoltz D.A., Ozer E.A., Ng C.J., Yu J.M., Reddy S.T., Lusis A.J., Bourquard N., Parsek M.R., Zabner J., Shih D.M. Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia. Am J Physiol Lung Cell Mol Physiol. 2007 Apr;292(4):L852-60.
  12. Witte I., Foerstermann U., Devarajan A., Reddy S.T., Horke S. Protectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and Cancer. J Lipids. 2012; 2012: 342806. doi: 10.1155/2012/342806.
  13. Schweikert E.M., Devarajan A., Witte I., Wilgenbus P., Amort J., Forstermann U., Shabazian A., Grijalva V., Shih D.M., Farias-Eisner R., Teiber J.F., Reddy S.T., Horke S. PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death Differ. 2012; 19: 1549–60. doi: 10.1038/cdd.2012.35.
  14. Ng C.J., Bourquard N., Grijalva V., Hama S., Shih D.M., Navab M., Fogelman A.M., Lusis A.J., Young S., Reddy S.T. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. J Biol Chem. 2006; 281: 29491–500. doi: 10.1074/jbc.M605379200
  15. Besler C., Heinrich K., Rohrer L., Doerries C., Riwanto M., Shih D.M., Chroni A., Yonekawa K., Stein S., Schaefer N., Mueller M., Akhmedov A., Daniil G., Manes C. Templin C., Wyss C., Maier W., Tanner F.C., Matter CM, Corti R, Furlong C, Lusis AJ, von Eckardstein A., Fogelman A.M., Lüscher T.F., Landmesser U. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest. 2011; 121(7): 2693–708. doi: 10.1172/JCI42946.
  16. Huang Y., Wu Z., Riwanto M., Gao S., Levison B. S., Gu X., et al. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest. 2013; 123(9): 3815–28. http://doi.org/10.1172/JCI67478
  17. Levy E., Trudel K., Bendayan M., Seidman E., Delvin E., Elchebly M., Lavoie J.C., Precourt L.P., Amre D., Sinnett D. Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats, Am J Physiol Gastrointest Liver Physiol. 2007; 293(6): G1252–61. doi: 10.1152/ajpgi.00369.2007
  18. Devarajan A., Bourquard N., Hama S., Navab M., Grijalva V.R., Morvardi S., Clarke C.F., Vergnes L., Reue K., Teiber J.F., Reddy S.T. Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis, Antioxid Redox Signal. 2011; 14: 341–51. doi: 10.1089/ars.2010.3430.
  19. Horke S., Witte I., Wilgenbus P., Altenhöfer S., Krüger M., Li H., Förstermann U. Protective effect of paraoxonase-2 against endoplasmic reticulum stress-induced apoptosis is lost upon disturbance of calcium homoeostasis. Biochem J. 2008; 416(3): 395–405. doi: 10.1042/BJ20080775.
  20. Reddy S.T., Wadleigh D.J., Grijalva V., Ng C., Hama S., Gangopadhyay A., Shih D.M., Lusis A.J., Navab M. Fogelman A.M. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol. 2001; 21: 542–7. doi: 10.1161/01.atv.21.4.542
  21. Боровкова Е.И., Антипова Н.В., Корнеенко Т.В., Шахпаронов М.И., Боровков И.М. Параоксоназа: универсальный фактор антиоксидантной защиты организма человека. Вестник Российской академии медицинских наук. 2017; 72(1): 5–10. [Borovkova EI, Antipova NV, Korneenko TV, Shakhparonov MI, Borovkov IM. Paraoxonase: The Universal Factor of Antioxidant Defense in Human Body. Annals of the Russian Academy of Medical Sciences. 2017; 72(1): 5-10. (In Russ.)]. https://doi.org/10.15690/vramn764
  22. Devarajan A., Shih D., Reddy S.T. Inflammation, Infection, Cancer and All That…The Role of Paraoxonases. Advances in Experimental Medicine and Biology. 2014; 824: 33–41. http://doi.org/10.1007/978-3-319-07320-0_5
  23. Kim D.S., Marsillach J., Furlong C.E., Jarvik G.P. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease. Pharmacogenomics. 2013; 14(12): 1495–1515. http://doi.org/10.2217/pgs.13.147
  24. Schweikert E.-M., Amort J., Wilgenbus P., Förstermann U., Teiber J. F., Horke S. Paraoxonases-2 and -3 Are Important Defense Enzymes against Pseudomonas aeruginosa Virulence Factors due to Their Anti-Oxidative and Anti-Inflammatory Properties. J Lipids. 2012; 2012: 352857. http://doi.org/10.1155/2012/352857.1155/2012/352857
  25. Bacchetti T., Ferretti G., Sahebkar A. The role of paraoxonase in cancer. Semin. Cancer Biol. 2017; 56: 72–86. doi: 10.1016/j.semcancer.2017.11.013.
  26. Шахпаронов М.И., Антипова Н.В., Шендер В.О., Шнайдер П.В., Арапиди Г.П., Песто Н.Б., Павлюков М.С. Экспрессия и внутриклеточная локализация параоксоназы 2 в опухолевых клетках различного типа. Acta Naturae. 2018; 10(3): 100–7. [Shakhparonov M.I., Antipova N.V., Shender V.O., Shnaider P.V., Arapidi G.P., Pestov N.B., Pavlyukov M.S. Expression and Intracellular Localization of Paraoxonase 2 in Different Types of Malignancies. Acta Naturae (англоязычная версия). 2018; 10(3): 92–9. (in Russian)].

Received 19.11.2019

Accepted 29.11.2019

About the Authors

Sergey A. Levakov, MD, PhD, professor, head of the Department of Obstetrics and Gynecology, FSAEI HE I.M.Sechenov First MSMU MOH, Russia.
Address: Trubetskaya street 8/2, Moscow, 119991, Russian Federation.
Natalya A. Sheshukova, MD, PhD, professor of the Department of Obstetrics and Gynecology, FSAEI HE I.M.Sechenov First MSMU MOH, Russia.
Address: Trubetskaya street 8/2, Moscow, 119991, Russian Federation.
Elizaveta A. Obukhova, graduate student of the Department of Obstetrics and Gynecology, FSAEI HE I.M.Sechenov First MSMU MOH, Russia.
Address: Trubetskaya street 8/2, Moscow, 119991, Russian Federation. E-mail: liza_obukhova@mail.ru
Nadezhda V. Antipova, Candidate of Biological Sciences, researcher of the Shemyakin-Ovchinnikov Institute of bioorganic chemistry of the Russian Academy of Sciences, associate professor of the Department of Pharmaceutical and Toxicological Chemistry of the Peoples’ Friendship University of Russia.
Address: 117997, Moscow, GSP-7, ul. Miklukho-Maklaya, d. 16/10
Mikhail I. Shakhparonov, Doctor of Chemical Sciences, Leading Researcher of the Shemyakin-Ovchinnikov Institute of bioorganic chemistry of the Russian Academy
of Sciences.
Address: 117997, Moscow, GSP-7, ul. Miklukho-Maklaya, d. 16/10.

For citation: Levakov S.A., Sheshukova N.A., Obukhova E.A., Antipova N.V., Shakhparonov M.I.: The role of paraoxonases in the pathogenesis of inflammatory and infectious diseases and cancer.
Akusherstvo i Ginekologiya/Obstetrics and gynecology. 2020; 3: 26-32. (In Russian).
https://dx.doi.org/10.18565/aig.2020.3.26-32

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.